Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 22 July 2008, doi:10.1136/bmj.a903
Cite this as: BMJ 2008;337:a903
| The first 150 words of the full text of this article appear below. |
Commenting on the systematic review by Lourenco et al,1 we wish to make several specific and general points.
The contention that holmium laser enucleation holds most promise in challenging transurethral prostatic ablation (TURP) belies the fact that this technique has a steep learning curve and requires careful morcellation of the prostate in the bladder once enucleated.
Since the systematic review was carried out, photoselective vaporisation (PVP—so called greenlight PVP laser of the prostate) has been used in many urology units. The short learning curve, day case nature with minimal to no bleeding, and ability to carry out ablation while patients are receiving anticoagulants have made this development in prostate management an extremely attractive option.2 Two randomised controlled trials have compared PVP against TURP, one with 6 months follow-up3 and one with 12 months follow-up.4 The latter showed equivalent flow rate and symptom score outcomes, alongside shorter length of stay, shorter
Hashim U Ahmed, MRC clinical research fellow, Manit Arya, specialist registrar urology, Mark Emberton, reader in interventional oncology
1 University College London, London W1P 7PN
hashim.ahmed@ucl.ac.uk